01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05.Introduction
06.Types of Contraceptive Methods
07.Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08.Market Segmentation by Product Type
09.Global Condoms Market
09.1 Market Size and Forecast
10.Global IUDs Market
10.1 Market Size and Forecast
11.Global Subdermal Contraceptive Implants Market
11.1 Market Size and Forecast
12.Global Vaginal Rings Market
12.1 Market Size and Forecast
13.Global Non-surgical Permanent Contraception Devices Market
13.1 Market Size and Forecast
14.Global Contraceptive Diaphragms Market
14.1 Market Size and Forecast
15.Global Contraceptive Sponges Market
15.1 Market Size and Forecast
16.Geographical Segmentation
16.1 Contraceptive Devices Market in Americas
16.1.1 Market Size and Forecast
16.2 Contraceptive Devices Market in EMEA
16.2.1 Market Size and Forecast
16.3 Contraceptive Devices Market in APAC
16.3.1 Market Size and Forecast
17.Buying Criteria
18.Market Growth Drivers
19.Drivers and Their Impact
20.Market Challenges
21.Impact of Drivers and Challenges
22.Market Trends
23.Trends and Their Impact
24.Vendor Landscape
24.1 Competitive Scenario
24.1.1 Key News
24.1.2 Mergers and Acquisitions
24.2 Market Share Analysis 2014
24.2.1 Actavis
24.2.2 Ansell
24.2.3 Bayer
24.2.4 Church & Dwight
24.2.5 Merck
24.3 Other Prominent Vendors
25.Key Vendor Analysis
25.1 Actavis
25.1.1 Key Facts
25.1.2 Business Overview
25.1.3 Business Segmentation
25.1.4 Business Segmentation by Revenue 2012 and 2013
25.1.5 Geographical Segmentation by Sales 2013
25.1.6 Business Strategy
25.1.7 Recent Developments
25.1.8 SWOT Analysis
25.2 Ansell
25.2.1 Key Facts
25.2.2 Business Overview
25.2.3 Business Segmentation by Revenue 2014
25.2.4 Business Segmentation by Revenue 2013 and 2014
25.2.5 Geographical Segmentation by Revenue 2014
25.2.6 Recent Developments
25.2.7 SWOT Analysis
25.3 Bayer
25.3.1 Key Facts
25.3.2 Business Overview
25.3.3 Business Segmentation by Revenue 2014
25.3.4 Business Segmentation by Revenue 2013 and 2014
25.3.5 Geographical Segmentation by Revenue 2014
25.3.6 Business Strategy
25.3.7 Recent Developments
25.3.8 SWOT Analysis
25.4 Church & Dwight
25.4.1 Key Facts
25.4.2 Business Overview
25.4.3 Business Segmentation by Revenue 2013
25.4.4 Business Segmentation by Revenue 2012 and 2013
25.4.5 Geographical Segmentation by Revenue 2013
25.4.6 Business Strategy
25.4.7 Recent Developments
25.4.8 SWOT Analysis
25.5 Merck
25.5.1 Key Facts
25.5.2 Business Overview
25.5.3 Business Segmentation by Revenue 2013
25.5.4 Business Segmentation by Revenue 2012 and 2013
25.5.5 Sales by Geography
25.5.6 Business Strategy
25.5.7 Key Developments
25.5.8 SWOT Analysis
26.Other Reports in This Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Market Overview
Exhibit 3: Global Contraceptive Devices Market 2014-2019 ($ millions)
Exhibit 4: Segmentation of Global Contraceptive Devices Market by Product Type
Exhibit 5: Segmentation of Global Contraceptive Devices Market by Product Type 2014
Exhibit 6: Global Condoms Market 2014-2019 ($ millions)
Exhibit 7: Global IUDs Market 2014-2019 ($ millions)
Exhibit 8: Global Subdermal Contraceptive Implants Market 2014-2019 ($ millions)
Exhibit 9: Global Vaginal Rings Market 2014-2019 ($ millions)
Exhibit 10: Global Non-surgical Permanent Contraception Devices Market 2014-2019 ($ millions)
Exhibit 11: Global Contraceptive Diaphragms Market 2014-2019 ($ millions)
Exhibit 12: Global Contraceptive Sponges Market 2014-2019 ($ millions)
Exhibit 13: Segmentation of Global Contraceptive Devices Market by Product Type 2014-2019 ($ millions)
Exhibit 14: Segmentation of Global Contraceptive Devices Market by Product Type 2014-2019
Exhibit 15: Segmentation of Global Contraceptive Devices Market by Geography 2014
Exhibit 16: Contraceptive Devices Market in Americas 2014-2019 ($ millions)
Exhibit 17: Contraceptive Devices Market in EMEA 2014-2019 ($ millions)
Exhibit 18: Contraceptive Devices Market in APAC 2014-2019 ($ millions)
Exhibit 19: Segmentation of Global Contraceptive Devices Market by Geography 2014-2019 ($ millions)
Exhibit 20: Segmentation of Global Contraceptive Devices Market by Geography 2014-2019
Exhibit 21: Major Drivers of Global Contraceptive Devices Market
Exhibit 22: STDs in US
Exhibit 23: Estimated Cases of STIs in US
Exhibit 24: Total Population Growth Rate and Crude Birthrate 2007-2012
Exhibit 25: Major Challenges in Global Contraceptive Devices Market
Exhibit 26: Major Trends in Global Contraceptive Devices Market
Exhibit 27: Global Fertility Rate 2007-2012
Exhibit 28: Actavis: Key Takeaways
Exhibit 29: Ansell: Key Takeaways
Exhibit 30: Bayer: Key Takeaways
Exhibit 31: Church & Dwight: Key Takeaways
Exhibit 32: Merck: Key Takeaways
Exhibit 33: Actavis: Business Segmentation
Exhibit 34: Actavis: Business Segmentation by Revenue 2012 and 2013 ($ millions)
Exhibit 35: Actavis: Geographical Segmentation by Sales 2013
Exhibit 36: Ansell: Business Segmentation by Revenue 2014
Exhibit 37: Ansell: Business Segmentation by Revenue 2013 and 2014 ($ millions)
Exhibit 38: Ansell: Geographical Segmentation by Revenue 2014
Exhibit 39: Bayer: Business Segmentation by Revenue 2014
Exhibit 40: Bayer: Business Segmentation by Revenue 2013 and 2014 ($ billions)
Exhibit 41: Bayer: Geographical Segmentation by Revenue 2014
Exhibit 42: Church & Dwight: Business Segmentation by Revenue 2013
Exhibit 43: Church & Dwight: Business Segmentation by Revenue 2012 and 2013 ($ billions)
Exhibit 44: Church & Dwight: Geographical Segmentation by Revenue 2013
Exhibit 45: Merck: Business Segmentation by Revenue 2013
Exhibit 46: Merck: Business Segmentation by Revenue 2012 and 2013 ($ billions)
Exhibit 47: Merck: Sales by Geography 2013
【掲載企業】
Ansell, Actavis, Bayer, Church & Dwight,Merck & Co, Agile Therapeutics, Caya, Condomi Health International, Fuji Latex, HLL Lifecare, Karex Industries, Lipocine, Mayer Laboratories, Medicines 360, Okamoto Industries, Reckitt Benckiser Group, Teva Pharmaceuticals, The Female Health Company, TodaySponge
【資料のキーワード】
避妊具、不妊、コンドーム、IUD、皮下避妊インプラント、避妊リング、妊娠、男性避妊、女性避妊
【調査方法】
一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)